Sotera Health Appoints Christopher Simon to the Board of Directors
August 01 2024 - 7:00AM
Sotera Health Company (Nasdaq: SHC), a leading global provider
of mission-critical end-to-end sterilization solutions and lab
testing and advisory services for the healthcare
industry, announced today it has appointed Christopher Simon
as a new independent director to its Board of Directors. Mr. Simon
will serve as a member of the Leadership Development and
Compensation Committee of the Board of Directors.
For approximately the past eight years, Mr. Simon
has served as the President and Chief Executive Officer of
Haemonetics Corporation (NYSE: HAE), a global medical technology
company, as well as a member of Haemonetics’ Board of Directors.
Previously, Mr. Simon served as a Senior Partner of McKinsey &
Company, a strategy and management consulting firm, where he led
the Global Medical Products Practice. Prior to his career at
McKinsey & Company, Mr. Simon served in commercial and
operating roles at Baxter Healthcare Corporation, now Baxter
International Inc., a healthcare company, and as a U.S. Army
Infantry Officer in Korea and with the 1st Ranger Battalion. He
brings more than 30 years of experience in helping businesses
transform and grow. “We are excited to welcome Chris to our Board
of Directors,” said Michael B. Petras, Jr., Chairman and Chief
Executive Officer of Sotera Health. “Chris’s leadership experience
as a public company CEO and his extensive commercial and strategic
experience in the life sciences industry will serve as tremendous
assets as we continue to grow.”
Mr. Simon also currently serves on the board of directors of
AdvaMed, a global trade association of companies that develop,
produce, manufacture and market medical technologies. Mr. Simon
earned a Bachelor of Science in Economics from The Wharton School
at the University of Pennsylvania and an MBA from Harvard Business
School.
About Sotera HealthSotera Health Company is a
leading global provider of mission-critical end-to-end
sterilization solutions and lab testing and advisory services for
the healthcare industry. Sotera Health goes to market through three
businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health
is committed to its mission, Safeguarding Global Health®.
Contacts |
|
Jason PetersonVice
President Investor Relations & Treasurer, Sotera
HealthIR@soterahealth.com |
|
|
|
|
|
Kristin GibbsChief Marketing
Officer, Sotera Healthkgibbs@soterahealth.com |
|
Source: Sotera Health Company
Haemonetics (NYSE:HAE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Haemonetics (NYSE:HAE)
Historical Stock Chart
From Oct 2023 to Oct 2024